Measures the Life Sciences Industry Can Take to Facilitate Diversity in Clinical Trials

Home / Intelligence / Podcasts / Measures the Life Sciences Industry Can Take to Facilitate Diversity in Clinical Trials

The importance of ensuring diversity in clinical trials is undisputed, but barriers across the healthcare ecosystem still exist; what can healthcare regulators, policy makers, and manufacturers do to overcome challenges when recruiting clinical trial participants?

Host, Matthew Rube, a Senior Consultant at Trinity Life Sciences, joins two of the subject-matter experts that authored Trinity Life Sciences’ cornerstone white paper to discuss why ensuring diversity in clinical trials participation is such a critical issue, the results of the team’s research, and the action-oriented recommendations that they have for the life sciences industry.


Michele Andrews Headshot

Michele Andrews
Principal, Strategic Advisory &
Head of Dynamic Market Intelligence

Monique Marsh Headshot

Monique Marsh
Associate Director of Primary Market Research & Head of Qualitative Innovation and Implementation

Matthew Rube Headshot

HOST: Matthew Rube
Senior Consultant,
Evidence, Value, Access and Pricing


Download the White Paper: Diversity in Clinical Trials Participation: A Life Sciences Perspective to understand how you and your organization can help to further diversity in clinical trials.

Thank you to everyone who contributed towards this important research: 

Peter Palumbo, Patrick Hong, Monique Marsh, Shanice O’Brien, Courtney Poopat, Catherine Toal, Michele Andrews, Herman Sanchez, Sumudu Dehipawala, UT Yadav, Alexander Fish, Peter Baek, Alessandra Moscoso, Shruti Nambiar, and Justin Li 

Related Intelligence


Diversity in Clinical Trials: Evaluating Current Initiatives and the Impending Impact of the FDA’s Guidance

Available On Demand

Trinity’s Diversity, Equity & Inclusion (DEI) strategy team invites life sciences executives to join a lively discussion on recent research and developments in clinical trial diversity with a focus on racial and ethnic minorities. Herman Sanchez, Chief Business Officer at Trinity Life Sciences, will host this session and moderate a panel with special guests Monique […]

 Watch Now

White Papers

Diversity in Clinical Trials: Life Sciences Initiatives and Challenges in Light of the FDA’s Latest Guidance

To date, life sciences’ efforts towards driving equitable healthcare have centered around access to care, early identification and prevention. Meanwhile, less attention has been given to the impact of the racial and ethnic homogeneity in trial populations. Clinical trial diversity continues to be one of the greatest challenges pharmaceutical and biotech companies face in ensuring […]

 Read More

White Papers

Diversity in Clinical Trials Participation: A Life Sciences Perspective

Providing optimal care to all patients is an imperative that unites the various, interconnected parts of the medical field, from primary care to the pharmaceutical industry to the work of large academic medical centers. Over the past 30 years, there have been exceptional advances in care, treatment, diagnostics, and early identification of disease. Unfortunately, even […]

 Read More